| Not Yet Recruiting | Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) NCT06084780 | Case Comprehensive Cancer Center | Phase 2 |
| Not Yet Recruiting | Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium NCT07378371 | Aerospace Center Hospital | N/A |
| Recruiting | One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei NCT07328737 | Beijing Tsinghua Chang Gung Hospital | N/A |
| Recruiting | Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei NCT07341360 | Oslo University Hospital | EARLY_Phase 1 |
| Completed | Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Tr NCT06839378 | Beijing Tsinghua Chang Gung Hospital | N/A |
| Recruiting | Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC- NCT06513065 | University of Southampton | Phase 3 |
| Recruiting | Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients NCT06800391 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Unknown | BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei NCT03976973 | Mucpharm Pty Ltd | Phase 2 |
| Recruiting | Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis NCT04024917 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Unknown | Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei NCT04982146 | Maimónides Biomedical Research Institute of Córdoba | Phase 1 |
| Completed | Severe Neutropenia After HIPEC Using Mitomycin-C NCT05513183 | Gangnam Severance Hospital | — |
| Terminated | A Study of SGN-STNV in Advanced Solid Tumors NCT04665921 | Seagen Inc. | Phase 1 |
| Withdrawn | What Are the Experiences of Patients With Pseudomyxoma Peritonei? NCT04125225 | University of Southampton | — |
| Completed | Phase I Trial HIPEC With Nal-irinotecan NCT04088786 | Stony Brook University | Phase 1 |
| Unknown | Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients NCT05321329 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) NCT03210298 | Sabine Rhode | — |
| Unknown | Gastrointestinal Microbiome Study of Appendiceal Cancer NCT02599116 | Mercy Medical Center | N/A |
| Completed | Thrombin Generation and Platelet Activation in CRS/HIPEC NCT03034850 | Ziekenhuis Oost-Limburg | — |
| Active Not Recruiting | Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin NCT02387203 | Mercy Medical Center | Phase 2 |
| Completed | HIPEC Using High Intra-abdominal Pressure NCT02949791 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Completed | Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients NCT02374411 | Edward Hospital | — |
| Completed | Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer NCT01652794 | Case Comprehensive Cancer Center | Phase 1 |
| Recruiting | Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed NCT01617382 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | HIPEC for Peritoneal Carcinomatosis NCT02040142 | Albert Einstein College of Medicine | Phase 2 |
| Completed | Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer NCT01764789 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | French National Registry of Rare Peritoneal Surface Malignancies NCT02834169 | Hospices Civils de Lyon | — |
| Completed | Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) NCT01126346 | Wake Forest University Health Sciences | N/A |
| Recruiting | Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies NCT02073500 | Oslo University Hospital | — |
| Unknown | Results of CRS and Debulking in PMP Patients NCT01427101 | Uppsala University | — |